Find the nearest Life Pharmacy where this item is available Overview Wegovy 1.5mg Tablets are a prescription-only, once-daily oral GLP-1 receptor agonist treatment containing semaglutide, developed by Novo Nordisk for adults living with obesity or overweight with weight-related health conditions
Avoid lying down for at least 23 hours after eating, as this can worsen nausea and increase the risk of regurgitation
Why weight is central Excess weight is not the only cause of sleep apnea, but it is one of the biggest risk factors
Reviews from real Noom users The bottom line: Switching from Wegovy to Zepbound is a personalized decision People switch from Wegovy to Zepbound for many reasons, including insurance coverage, cost, medication availability, side effects, or slower-than-expected weight loss
Many people report that theyve adapted to these conditions to the point of not fully recognizing them as symptoms until they begin to change